Sollte ich methylthiophenyl morpholino isobutanone in der Schwangerschaft meiden? | VeriMom
This substance (2‑methyl‑1‑(4‑methylthiophenyl)‑2‑morpholinopropan‑1‑one; CAS 71868‑10‑5) has an EU harmonised CLP classification as Toxic for Reproduction Category 1B, H360FD (“May damage fertility. May damage the unborn child”), which places it in the highest reproductive hazard category and justifies h=3. ECHA’s supporting background/briefing documents and Annex VI entry report reproductive toxicity data from regulatory assessments (animal datasets) though a specific molecular mechanism is not fully characterised; therefore m=2 (demonstrated effect in studies). Topical cosmetic exposure data are limited and it has historically been used in non‑leave‑on products / industrial applications; in absence of quantitative dermal absorption data I score exposure as low but measurable (e=1). Sources: ECHA harmonised CLP / Annex VI recommendation and background documents, ECHA brief profile.
ECHA regulatory hazard statements
- •H360FD
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist methylthiophenyl morpholino isobutanone in der Schwangerschaft sicher?
- This substance (2‑methyl‑1‑(4‑methylthiophenyl)‑2‑morpholinopropan‑1‑one; CAS 71868‑10‑5) has an EU harmonised CLP classification as Toxic for Reproduction Category 1B, H360FD (“May damage fertility. May damage the unborn child”), which places it in the highest reproductive hazard category and justifies h=3. ECHA’s supporting background/briefing documents and Annex VI entry report reproductive toxicity data from regulatory assessments (animal datasets) though a specific molecular mechanism is not fully characterised; therefore m=2 (demonstrated effect in studies). Topical cosmetic exposure data are limited and it has historically been used in non‑leave‑on products / industrial applications; in absence of quantitative dermal absorption data I score exposure as low but measurable (e=1). Sources: ECHA harmonised CLP / Annex VI recommendation and background documents, ECHA brief profile.
- Ist methylthiophenyl morpholino isobutanone während des Stillens sicher?
- Harmonised H360FD (may damage fertility and the unborn child) indicates high reproductive hazard (h=3) and the regulatory dossier shows animal reproductive toxicity evidence (m=2). There are no public quantitative data on human milk transfer; exposure from typical topical cosmetic use is likely low but measurable (e=1) — breastfeeding concern derives from systemic hazard plus potential for maternal systemic exposure. Sources: ECHA harmonised classification and background documents.
- Ist methylthiophenyl morpholino isobutanone sicher für Babyhaut?
- Hazard (h=3) remains because of the substance’s harmonised H360FD reproduction/teratogenic classification. Mechanistic evidence remains regulatory/animal‑based rather than a well‑characterised molecular pathway (m=2). For infant skin (0–3 yr) exposure I increase exposure by +1 relative to adults (adult e=1 → baby e=2) because infant skin has higher surface‑area‑to‑weight and an immature barrier and there are no reliable dermal absorption data showing non‑absorbability. Together this yields higher concern for use on or near infants. Sources: ECHA harmonised CLP / background documents; PubChem substance record.
- Wie bewertet VeriMom methylthiophenyl morpholino isobutanone?
- VeriMom bewertet methylthiophenyl morpholino isobutanone mit 20/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu methylthiophenyl morpholino isobutanone?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu methylthiophenyl morpholino isobutanone basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.